Viral enzymes

Current Opinion in Structural Biology

Volumn 16, Issue 6, 2006, Pages 776-786

  Mesters, Jeroen R ^a   Tan, Jinzhi ^a   Hilgenfeld, Rolf ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BACTERIAL ENZYME; CHYMOTRYPSIN; DNA POLYMERASE; DOUBLE STRANDED DNA; GENOMIC RNA; GLYCOSYLTRANSFERASE; GUANOSINE DIPHOSPHATE MANNOSE; MESSENGER RNA; NUCLEIC ACID; OSELTAMIVIR; OXIDOREDUCTASE; PROTEINASE; RNA POLYMERASE; SIALIDASE INHIBITOR; SINGLE STRANDED DNA; THIOREDOXIN; UBIQUITIN PROTEIN LIGASE; VIRUS ENZYME; VIRUS PROTEIN; VIRUS RNA; ZANAMIVIR;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CELL COMPARTMENTALIZATION; CHLORELLA VIRUS; ENZYME ACTIVITY; ENZYME STRUCTURE; HEPATITIS C VIRUS; HOST RESISTANCE; IMMUNE RESPONSE; INFLUENZA VIRUS; MACROMOLECULE; NONHUMAN; NUCLEIC ACID SYNTHESIS; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; REVIEW; RNA BINDING; RNA TRANSLATION; STRUCTURAL PROTEOMICS; VACCINIA VIRUS; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS REPLICATION; VIRUS SURVIVAL; VIRUS TRANSCRIPTION;

DNA REPLICATION; MODELS, MOLECULAR; PROTEIN CONFORMATION; VIRAL PHYSIOLOGY; VIRAL PROTEINS; VIRUS REPLICATION; VIRUSES;

EID: 34648854782     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2006.10.010     Document Type: Review

References (85)

1. In: Fauquet C.M., Mayo M.A., Maniloff J., Desselberger U., and Ball L.A. (Eds). Virus Taxonomy - VIIIth Report of the International Committee on Taxonomy of Viruses (2005), Academic Press, London
2. Schibli D.J., and Weissenhorn W. Class I and class II viral fusion protein structures reveal similar principles in membrane fusion. Mol Membr Biol 21 (2004) 361-371
3. Bartlam M., Yang H., and Rao Z. Structural insights into SARS coronavirus proteins. Curr Opin Struct Biol 15 (2005) 664-672
4. Yin H.S., Wen X., Paterson R.G., Lamb R.A., and Jardetzky T.S. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature 439 (2006) 38-44
5. Roussel A., Lescar J., Vaney M.C., Wengler G., Wengler G., and Rey F.A. Structure and interactions at the viral surface of the envelope protein E1 of Semliki Forest virus. Structure 14 (2006) 75-86
6. Modis Y., Ogata S., Clements D., and Harrison S.C. Structure of the dengue virus envelope protein after membrane fusion. Nature 427 (2004) 313-319
7. Mukhopadhyay S., Kuhn R.J., and Rossmann M.G. A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 3 (2005) 13-22
8. Heldwein E.E., Lou H., Bender F.C., Cohen G.H., Eisenberg R.J., and Harrison S.C. Crystal structure of glycoprotein B from herpes simplex virus 1. Science 313 (2006) 217-220
9. Russell R.J., Haire L.F., Stevens D.J., Collins P.J., Lin Y.P., Blackburn G.M., Hay A.J., Gamblin S.J., and Skehel J.J. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 443 (2006) 45-49. The first X-ray structure of an avian influenza type-I neuraminidase reveals an extra cavity adjacent to the active site observed in structures of type-II variants. The latter were used for structure-based design of oseltamivir and zanamivir. Clearly, this cavity can be exploited for structure-based design of new neuraminidase type-I specific inhibitors.
10. Meylan E., and Tschopp J. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Mol Cell 22 (2006) 561-569
11. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., and Tschopp J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 (2005) 1167-1172. The authors describe a new CARD-containing adaptor protein, Cardif, which interacts with RIG-I, a helicase that senses double-stranded (viral) RNA. Cardif can recruit several kinases, thereby stimulating NF-κB and IRF3 promoter activation. Interestingly, in order to perturb the host's immune response (e.g. interferon-β production), Cardif is targeted and inactivated by the NS3-NS4A serine protease of HCV.
12. Li T., Chen X., Garbutt K.C., Zhou P., and Zheng N. Structure of DDB1 in complex with a paramyxovirus V protein: viral hijack of a propeller cluster in ubiquitin ligase. Cell 124 (2006) 105-117. The quaternary structure of the complex between simian virus 5 V protein and DNA damage binding protein 1 (of the DDB1-Cul4A ubiquitin ligase complex) reveals how a single viral protein can reprogram a cellular pathway, inducing degradation of STATs and thereby obstructing interferon signaling. This is achieved by the insertion a single helix of the 5 V protein into a pocket formed by two domains of the three-β-propeller DDB1 structure.
13. Langland J.O., Cameron J.M., Heck M.C., Jancovich J.K., and Jacobs B.L. Inhibition of PKR by RNA and DNA viruses. Virus Res 119 (2006) 100-110
14. Hakki M, Marshall EE, De Niro KL, Geballe AP: Binding and nuclear relocalization of PKR by human cytomegalovirus TRS1. J Virol 2006, in press.
15. Lloyd R.E. Translational control by viral proteinases. Virus Res 119 (2006) 76-88
16. Alvarez E., Castello A., Menendez-Arias L., and Carrasco L. HIV protease cleaves poly(A)-binding protein. Biochem J 396 (2006) 219-226
17. Baxter N.J., Roetzer A., Liebig H.D., Sedelnikova S.E., Hounslow A.M., Skern T., and Waltho J.P. Structure and dynamics of coxsackievirus B4 2A proteinase, an enzyme involved in the etiology of heart disease. J Virol 80 (2006) 1451-1462
18. Daughenbaugh K.F., Wobus C.E., and Hardy M.E. VPg of murine norovirus binds translation initiation factors in infected cells. Virol J 3 (2006) 33
19. Barends S., Bink H.H., van den Worm S.H., Pleij C.W., and Kraal B. Entrapping ribosomes for viral translation: tRNA mimicry as a molecular Trojan horse. Cell 112 (2003) 123-129
20. Raoult D., Audic S., Robert C., Abergel C., Renesto P., Ogata H., La Scola B., Suzan M., and Claverie J.M. The 1.2-megabase genome sequence of Mimivirus. Science 306 (2004) 1344-1350
21. Ferrer-Orta C., Arias A., Escarmis C., and Verdaguer N. A comparison of viral RNA-dependent RNA polymerases. Curr Opin Struct Biol 16 (2006) 27-34
22. Ferrer-Orta C., Arias A., Agudo R., Perez-Luque R., Escarmis C., Domingo E., and Verdaguer N. The structure of a protein primer-polymerase complex in the initiation of genome replication. EMBO J 25 (2006) 880-888. The first reported structure of a protein primer-polymerase complex involved in the initiation of viral genome replication. Protein primer VPg lines the RNA-binding cleft of RdRp, positioning its Tyr3 OH group as a molecular mimic of the free 3′ OH group of a nucleic acid primer at the active site for nucleotidylylation. Moreover, VPg-UMP, the product of the nucleotidylylation reaction, is observed within the crystal structure.
23. Ferrer-Orta C., Arias A., Perez-Luque R., Escarmís C., Domingo E., and Verdaguer N. Structure of foot-and-mouth disease virus RNA-dependent RNA polymerase and its complex with a template-primer RNA. J Biol Chem 279 (2004) 47212-47221
24. Appleby T.C., Luecke H., Shim J.H., Wu J.Z., Cheney I.W., Zhong W., Vogeley L., Hong Z., and Yao N. Crystal structure of complete rhinovirus RNA polymerase suggests front loading of protein primer. J Virol 79 (2005) 277-288. Based on the X-ray structure of human rhinovirus 16 3D RNA-dependent RNA polymerase, the authors argue in favor of a so-called front-loading model for VPg binding and uridylylation.
25. Love R.A., Maegley K.A., Yu X., Ferre R.A., Lingardo L.K., Diehl W., Parge H.E., Dragovich P.S., and Fuhrman S.A. The crystal structure of the RNA-dependent RNA polymerase from human rhinovirus: a dual function target for common cold antiviral therapy. Structure 12 (2004) 1533-1544
26. Choi K.H., Groarke J.M., Young D.C., Kuhn R.J., Smith J.L., Pevear D.C., and Rossmann M.G. The structure of the RNA-dependent RNA polymerase from bovine viral diarrhea virus establishes the role of GTP in de novo initiation. Proc Natl Acad Sci USA 101 (2004) 4425-4430. The structure of bovine viral diarrhea virus polymerase with a bound GTP molecule, required in addition to the initiation NTP, reveals that the GTP in fact substitutes for a primer RNA in de novo (primer-independent) initiation of replication.
27. Biswal B.K., Wang M., Cherney M.M., Chan L., Yannopoulos C.G., Bilimoria D., Bedard J., and James M.N. Non-nucleoside inhibitors binding to hepatitis C virus NS5B polymerase reveal a novel mechanism of inhibition. J Mol Biol 361 (2006) 33-45
28. Biswal B.K., Cherney M.M., Wang M., Chan L., Yannopoulos C.G., Bilimoria D., Nicolas O., Bedard J., and James M.N. Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by non-nucleoside inhibitors. J Biol Chem 280 (2005) 18202-18210. Two conformations are reported for RdRp genotype 2a from HCV: an open, active, form and a closed, inactive, one. NNIs apparently bind exclusively to an allosteric patch of the open form, located 35 Å away from the active site.
29. Tellinghuisen T.L., Marcotrigiano J., and Rice C.M. Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature 435 (2005) 374-379
30. Moradpour D., Brass V., and Penin F. Function follows form: the structure of the N-terminal domain of HCV NS5A. Hepatology 42 (2005) 732-735
31. Sapay N., Montserret R., Chipot C., Brass V., Moradpour D., Deleage G., and Penin F. NMR structure and molecular dynamics of the in-plane membrane anchor of nonstructural protein 5A from bovine viral diarrhea virus. Biochemistry 45 (2006) 2221-2233
32. Moure C.M., Bowman B.R., Gershon P.D., and Quiocho F.A. Crystal structures of the vaccinia virus polyadenylate polymerase heterodimer: insights into ATP selectivity and processivity. Mol Cell 22 (2006) 339-349. The first structure of a viral polyadenylate polymerase is presented. The reported vaccinia virus heterodimeric structure is made up of a catalytic component (polymerase VP55) and a cap-specific mRNA (nucleoside-2′-O-)-methyltransferase (VP39). The VP55 protein reveals an unusual architecture that differs from many known polymerases, including the eukaryotic poly(A) polymerases.
33. Appleton B.A., Brooks J., Loregian A., Filman D.J., Coen D.M., and Hogle J.M. Crystal structure of the cytomegalovirus DNA polymerase subunit UL44 in complex with the C terminus from the catalytic subunit. Differences in structure and function relative to unliganded UL44. J Biol Chem 281 (2006) 5224-5232
34. Liu S., Knafels J.D., Chang J.S., Waszak G.A., Baldwin E.T., Deibel Jr. M.R., Thomsen D.R., Homa F.L., Wells P.A., Tory M.C., et al. Crystal structure of the herpes simplex virus 1 DNA polymerase. J Biol Chem 281 (2006) 18193-18200
35. Zhai Y., Sun F., Li X., Pang H., Xu X., Bartlam M., and Rao Z. Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer. Nat Struct Mol Biol 12 (2005) 980-986. This fine paper provides insight into the complexity of the coronavirus replicase machinery. The crystal structure of the hexadecameric complex between Nsp7 and Nsp8 is described in great detail. Nsp8 adopts two very different conformations in the complex.
36. Egloff M.P., Ferron F., Campanacci V., Longhi S., Rancurel C., Dutartre H., Snijder E.J., Gorbalenya A.E., Cambillau C., and Canard B. The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world. Proc Natl Acad Sci USA 101 (2004) 3792-3796
37. Sutton G., Fry E., Carter L., Sainsbury S., Walter T., Nettleship J., Berrow N., Owens R., Gilbert R., Davidson A., et al. The nsp9 replicase protein of SARS-coronavirus, structure and functional insights. Structure 12 (2004) 341-353
38. Matthes N., Mesters J.R., Coutard B., Canard B., Snijder E.J., Moll R.G., and Hilgenfeld R. The non-structural protein Nsp10 of mouse hepatitis virus binds zinc ions and nucleic acids. FEBS Lett 580 (2006) 4143-4149
39. Su D., Lou Z., Sun F., Zhai Y., Yang H., Zhang R., Joachimiak A., Zhang X.C., Bartlam M., and Rao Z. Dodecamer structure of severe acute respiratory syndrome coronavirus nonstructural protein nsp10. J Virol 80 (2006) 7902-7908
40. Joseph J.S., Saikatendu K.S., Subramanian V., Neuman B.W., Brooun A., Griffith M., Moy K., Yadav M.K., Velasquez J., Buchmeier M.J., et al. Crystal structure of nonstructural protein 10 from the severe acute respiratory syndrome coronavirus reveals a novel fold with two zinc-binding motifs. J Virol 80 (2006) 7894-7901
41. Saikatendu K.S., Joseph J.S., Subramanian V., Clayton T., Griffith M., Moy K., Velasquez J., Neuman B.W., Buchmeier M.J., Stevens R.C., and Kuhn P. Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1′′-phosphate dephosphorylation by a conserved domain of nsP3. Structure 13 (2005) 1665-1675
42. Egloff M.P., Malet H., Putics A., Heinonen M., Dutartre H., Frangeul A., Gruez A., Campanacci V., Cambillau C., Ziebuhr J., et al. Structural and functional basis for ADP-ribose and poly(ADP-ribose) binding by viral macro domains. J Virol 80 (2006) 8493-8502. The authors show that Nsp3, a macrodomain or viral X-domain found in proteins associated with particular histones or involved in chromatin metabolism, actually displays poor ADRP activity (its proposed function). Instead, Nsp3 is shown to efficiently bind poly(ADP-ribose) in vitro. As a consequence, the true biological function of this protein remains to be elucidated.
43. Ricagno S., Egloff M.P., Ulferts R., Coutard B., Nurizzo D., Campanacci V., Cambillau C., Ziebuhr J., and Canard B. Crystal structure and mechanistic determinants of SARS coronavirus nonstructural protein 15 define an endoribonuclease family. Proc Natl Acad Sci USA 103 (2006) 11892-11897. The replicase complex of the nidoviruses includes an RNA endoribonuclease. The SARS-CoV Nsp15 protein exhibits a unique fold and assembles into a hexamer with six peripheral active sites. The spatial arrangement of the catalytic residues in the active site defines a separate endoribonuclease family, endoU.
44. Xu X., Zhai Y., Sun F., Lou Z., Su D., Xu Y., Zhang R., Joachimiak A., Zhang X.C., Bartlam M., and Rao Z. New antiviral target revealed by the hexameric structure of mouse hepatitis virus nonstructural protein nsp15. J Virol 80 (2006) 7909-7917. The mouse hepatitis virus Nsp15 protein was one the first members of the endoribonuclease endoU family to have its structure unveiled. The fully biological active unit is a dimer of trimers that is specific for uridylate. No structural homologues could be identified for the butterfly-shaped Nsp15 monomer as a whole or for any of its single domains.
45. Yao N., Hesson T., Cable M., Hong Z., Kwong A.D., Le H.V., and Weber P.C. Structure of the hepatitis C virus RNA helicase domain. Nat Struct Biol 4 (1997) 463-467
46. Wu J., Bera A.K., Kuhn R.J., and Smith J.L. Structure of the Flavivirus helicase: implications for catalytic activity, protein interactions, and proteolytic processing. J Virol 79 (2005) 10268-10277. This structure reveals that the adenine and ribose moieties of a bound ADP, in the YFV helicase-nucleotide complex, protrude into solution; this nicely correlates with the reported lack of nucleotide specificity.
47. Xu T., Sampath A., Chao A., Wen D., Nanao M., Chene P., Vasudevan S.G., and Lescar J. Structure of the Dengue virus helicase/nucleoside triphosphatase catalytic domain at a resolution of 2.4 Å. J Virol 79 (2005) 10278-10288
48. Enemark E.J., and Joshua-Tor L. Mechanism of DNA translocation in a replicative hexameric helicase. Nature 442 (2006) 270-275. The E1 protein subunit of papillomavirus possesses two DNA-binding elements, a loop and a helix. Initially, two E1 homodimers are loaded onto separate strands of the dsDNA. The authors report the hexameric structure, disclosing that only one strand of DNA passes through the central channel. The DNA-binding loops of the subunits are proposed to sequentially track the oligonucleotide backbone. This hexameric structure represents the last step in assembling the helicase complex around ssDNA.
49. Enemark E.J., Stenlund A., and Joshua-Tor L. Crystal structures of two intermediates in the assembly of the papillomavirus replication initiation complex. EMBO J 21 (2002) 1487-1496
50. Su H.P., Lin D.Y., and Garboczi D.N. The structure of g4, the poxvirus disulfide oxidoreductase essential for virus maturation and infectivity. J Virol 80 (2006) 7706-7713
51. Feldman A.R., Lee J., Delmas B., and Paetzel M. Crystal structure of a novel viral protease with a serine/lysine catalytic dyad mechanism. J Mol Biol 358 (2006) 1378-1389. The first example of the unusual Ser-Lys catalytic dyad in a viral protease. A useful comparison with other proteases featuring this dyad, such as Lon, LexA and E. coli signal peptidase, is presented.
52. Nakamura K., Someya Y., Kumasaka T., Ueno G., Yamamoto M., Sato T., Takeda N., Miyamura T., and Tanaka N. A norovirus protease structure provides insights into active and substrate binding site integrity. J Virol 79 (2005) 13685-13693
53. Zeitler C.E., Estes M.K., and Venkataram Prasad B.V. X-ray crystallographic structure of the Norwalk virus protease at 1.5 Å resolution. J Virol 80 (2006) 5050-5058
54. Birtley J.R., Knox S.R., Jaulent A.M., Brick P., Leatherbarrow R.J., and Curry S. Crystal structure of foot-and-mouth disease virus 3C protease. J Biol Chem 280 (2005) 11520-11527
55. Nunn C.M., Jeeves M., Cliff M.J., Urquhart G.T., George R.R., Chao L.H., Tscuchia Y., and Djordjevic S. Crystal structure of tobacco etch virus protease shows the protein C terminus bound within the active site. J Mol Biol 350 (2005) 145-155
56. Phan J., Zdanov A., Evdokimov A.G., Tropea J.E., Peters H.K., Kapust R.B., Li M., Wlodawer A., and Waugh D.S. Structural basis for the substrate specificity of tobacco etch virus protease. J Biol Chem 277 (2002) 50564-50572
57. Bergmann E.M., Cherney M.M., McKendrick J., Frormann S., Luo C., Malcolm B.A., Vederas J.C., and James M.N. Crystal structure of an inhibitor complex of the 3C proteinase from hepatitis A virus (HAV) and implications for the polyprotein processing in HAV. Virology 265 (1999) 153-163
58. Mosimann S.C., Cherney M.M., Sia S., Plotch S., and James M.N. Refined X-ray crystallographic structure of the poliovirus 3C gene product. J Mol Biol 273 (1997) 1032-1047
59. Matthews D.A., Smith W.W., Ferre R.A., Condon B., Budahazi G., Sission W., Villafranca J.E., Janson C.A., McElroy H.E., Gribskov C.L., and Worland S. Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. Cell 77 (1994) 761-771
60. Satheshkumar P.S., Gayathri P., Prasad K., and Savithri H.S. "Natively unfolded" VPg is essential for Sesbania mosaic virus serine protease activity. J Biol Chem 280 (2005) 30291-30300. This paper describes the interesting observation that VPg is necessary for the activity of SeMV serine protease. The repertoire of described VPg activities continues to grow.
61. •]. The VPg is not bound to the enzyme in this structure, but a binding site has been assigned with a reasonable degree of certainty.
62. Kim J.L., Morgenstern K.A., Lin C., Fox T., Dwyer M.D., Landro J.A., Chambers S.P., Markland W., Lepre C.H., et al. Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 87 (1996) 343-355
63. Ontoria J.M., Di Marco S., Conte I., Di Francesco M.E., Gardelli C., Koch U., Matassa V.G., Poma M., Steinkühler C., Volpari C., and Harper S. The design and enzyme-bound crystal structure of indoline based peptidomimetic inhibitors of hepatitis C virus NS3 protease. J Med Chem 47 (2004) 6443-6446
64. Anand K., Palm G.J., Mesters J.R., Siddell S.G., Ziebuhr J., and Hilgenfeld R. Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain. EMBO J 21 (2002) 3213-3224
65. pro) structure: basis for design of anti-SARS drugs. Science 300 (2003) 1763-1767
66. Yang H., Yang M., Ding Y., Liu Y., Lou Z., Zhou Z., Sun L., Mo L., Ye S., Pang H., et al. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc Natl Acad Sci USA 100 (2003) 13190-13195
67. Groneberg D.A., Hilgenfeld R., and Zabel P. Molecular mechanisms of severe acute respiratory syndrome (SARS). Respir Res 6 (2005) 8-23
68. Anand K., Yang H., Bartlam M., Rao Z., and Hilgenfeld R. Coronavirus main proteinase: target for antiviral drug therapy. In: Schmidt A., Wolf M.H., and Weber O. (Eds). Coronaviruses with Special Emphasis on First Insights Concerning SARS (2005), Birkhäuser, Basel 173-199
69. pro) dimer: molecular dynamics simulations and multiple X-ray structure analyses. J Mol Biol 354 (2005) 25-40. This paper describes two new crystal forms of SARS-CoV main proteinase that provide valuable information on the dynamics of the enzyme. Also, the pH-dependent activation switch, observed previously by determining structures at different pH values, is simulated by molecular dynamics and shown to be triggered by protonation and deprotonation of two histidine residues in the substrate-binding site.
70. Xu T., Ooi A., Lee H.C., Wilmouth R., Liu D.X., and Lescar J. Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimmer. Acta Crystallogr F 61 (2005) 964-966
71. Yang H., Xie W., Xue X., Yang K., Ma J., Liang W., Zhao Q., Zhou Z., Pei D., Ziebuhr J., et al. Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol 3 (2005) e324. Starting from the previous proposal that vinylogous alkyl ester derivatives of substrate-like peptides may be potent inhibitors of coronavirus proteinases, the optimization of such compounds and their crystal structures with the main proteinases of several coronaviruses are described. This useful study demonstrates how antiviral drugs with the desired, relatively broad, activity can be designed.
72. Lee T.W., Cherney M.M., Huitema C., Liu J., James K.E., Powers J.C., Eltis L.D., and James M.N. Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide. J Mol Biol 353 (2005) 1137-1151
73. Yang S., Chen S.J., Hsu M.F., Wu J.D., Tseng C.T., Liu Y.F., Chen H.C., Kuo C.W., Wu C.S., Chang L.W., et al. Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor. J Med Chem 49 (2006) 4971-4980
74. Wu C.Y., King K.Y., Kuo C.J., Fang J.M., Wu Y.T., Ho M.Y., Liao C.L., Shie J.J., Liang P.H., and Wong C.H. Stable benzotriazole esters as mechanism-based inactivators of the severe acute respiratory syndrome 3CL protease. Chem Biol 13 (2006) 261-268
75. Hilgenfeld R., and Pumpor K. Sometimes intermediates do the job!. Chem Biol 13 (2006) 235-236
76. pro) inhibitors. ChemBioChem 7 (2006) 1048-1055
77. Chen L., Gui C., Luo X., Yang Q., Günther S., Scandella E., Drosten C., Bai D., He X., Ludewig B., et al. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J Virol 79 (2005) 7095-7103
78. Sulea T., Lindner H.A., Purisima E.O., and Menard R. Deubiquitination, a new function of the severe acute respiratory syndrome coronavirus papain-like protease?. J Virol 79 (2005) 4550-4551
79. Barretto N., Jukneliene D., Ratia K., Chen Z., Mesecar A.D., and Baker S.C. The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J Virol 79 (2005) 15189-15198
80. Lindner H.A., Fotouhi-Ardakani N., Lytvyn V., Lachance P., Sulea T., and Menard R. The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme. J Virol 79 (2005) 15199-15208
81. Ratia K., Saikatendu K.S., Santarsiero B.D., Barretto N., Baker S.C., Stevens R.C., and Mesecar A.D. Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme. Proc Natl Acad USA 103 (2006) 5717-5722. The crystal structure of the papain-like protease, the second protease of the SARS coronavirus, is presented here. Interestingly, the enzyme has been shown to have deubiquitinating activity, in addition to its protease function. In agreement with this, the three-dimensional structure is reminiscent of cellular deubiquitinases such as HAUSP.
82. Zhao C., Denison C., Huibregtse J.M., Gygi S., and Krug R.M. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci USA 102 (2005) 10200-10205
83. Rosano C., Zuccotti S., Sturla L., Fruscione F., Tonetti M., and Bolognesi M. Quaternary assembly and crystal structure of GDP-D-mannose 4,6 dehydratase from Paramecium bursaria Chlorella virus. Biochem Biophys Res Commun 339 (2006) 191-195
84. Larson E.T., Reiter D., Young M., and Lawrence C.M. Structure of A197 from Sulfolobus turreted icosahedral virus: a crenarchaeal viral glycosyltransferase exhibiting the GT-A fold. J Virol 80 (2006) 7637-7644
85. Imbert I., Guillemot J.C., Bourhis J.M., Bussetta C., Coutard B., Egloff M.P., Ferron F., Gorbalenya A.E., and Canard B. A second, non-canonical RNA-dependent RNA polymerase in SARS coronavirus. EMBO J 25 (2006) 4933-4942